Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
26.97
+0.57 (2.16%)
At close: Jul 30, 2026, 4:00 PM EDT
26.97
0.00 (0.00%)
After-hours: Jul 30, 2026, 7:34 PM EDT
Pacira BioSciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 144.31 | 158.55 | 276.77 | 153.3 | 104.14 | 585.58 |
Short-Term Investments | 57.87 | 79.88 | 207.84 | 125.28 | 184.51 | 70.83 |
Cash & Short-Term Investments | 202.18 | 238.42 | 484.62 | 278.58 | 288.65 | 656.41 |
Cash Growth | -59.04% | -50.80% | 73.96% | -3.49% | -56.03% | 25.83% |
Accounts Receivable | 125.64 | 124.07 | 113.3 | 105.56 | 98.4 | 96.32 |
Inventory | 150.37 | 152.86 | 125.28 | 104.35 | 96.06 | 98.55 |
Other Current Assets | 36.78 | 32.62 | 21.93 | 21.5 | 15.22 | 14.77 |
Total Current Assets | 514.96 | 547.97 | 745.13 | 509.99 | 498.33 | 866.05 |
Net Property, Plant & Equipment | 175.69 | 182.47 | 216.39 | 234.95 | 254.39 | 264.81 |
Other Intangible Assets | 353.23 | 368.1 | 425.97 | 483.26 | 540.55 | 623.97 |
Goodwill | 19.77 | 20.21 | - | 163.24 | 163.24 | 145.18 |
Long-Term Investments | - | - | - | 2.41 | 37.21 | - |
Other Long-Term Assets | 144.88 | 146.16 | 166.03 | 180.53 | 187.48 | 175.35 |
Total Assets | 1,209 | 1,265 | 1,554 | 1,574 | 1,681 | 2,075 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 14.01 | 15.15 | 19.13 | 15.7 | 15.22 | 10.54 |
Accrued Expenses | 84.96 | 95.6 | 80.12 | 64.24 | 89.79 | 127.56 |
Current Portion of Long-Term Debt | - | - | 201.78 | 8.64 | 33.65 | 374.7 |
Current Portion of Leases | 9.82 | 9.84 | 8.89 | 8.8 | 9.12 | 7.89 |
Other Current Liabilities | - | - | - | - | - | 0.43 |
Total Current Liabilities | 108.79 | 120.59 | 309.92 | 97.38 | 147.77 | 521.12 |
Long-Term Debt | 367.66 | 372.19 | 383.55 | 513.8 | 655.82 | 674.53 |
Long-Term Leases | 33.71 | 36.18 | 44.65 | 54.81 | 64.8 | 71.73 |
Other Long-Term Liabilities | 44.49 | 42.85 | 37.06 | 38.27 | 37.79 | 77.57 |
Total Long-Term Liabilities | 445.85 | 451.22 | 465.25 | 606.87 | 758.42 | 823.83 |
Total Liabilities | 554.64 | 571.81 | 775.17 | 704.26 | 906.19 | 1,345 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Treasury Stock | -227.01 | -176.57 | -25.12 | - | - | - |
Additional Paid-in Capital | 1,074 | 1,065 | 1,009 | 976.63 | 924.1 | 942.09 |
Accumulated Other Comprehensive Income | 3.46 | 4.33 | 0.34 | 0.25 | -0.38 | 0.17 |
Retained Earnings | -196.41 | -199.32 | -206.36 | -106.8 | -148.75 | -211.9 |
Shareholders' Equity | 653.89 | 693.11 | 778.35 | 870.13 | 775.01 | 730.41 |
Total Liabilities & Equity | 1,209 | 1,265 | 1,554 | 1,574 | 1,681 | 2,075 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 411.18 | 418.2 | 638.85 | 586.04 | 763.39 | 1,129 |
Net Cash (Debt) | -209 | -179.78 | -154.24 | -307.46 | -474.74 | -472.44 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -4.81 | -3.99 | -3.33 | -5.92 | -10.20 | -10.35 |
Book Value | 653.89 | 693.11 | 778.35 | 870.13 | 775.01 | 730.41 |
Book Value Per Share | 15.05 | 15.39 | 16.83 | 16.74 | 16.65 | 16.01 |
Tangible Book Value | 280.89 | 304.8 | 352.38 | 223.63 | 71.22 | -38.74 |
Tangible Book Value Per Share | 6.46 | 6.77 | 7.62 | 4.30 | 1.53 | -0.85 |